- Open Access
Correction to: Current outlook on radionuclide delivery systems: from design consideration to translation into clinics
Journal of Nanobiotechnology volume 18, Article number: 2 (2020)
- The original article was published in Journal of Nanobiotechnology 2019 17:90
Correction to: J Nanobiotechnol (2019) 17:90 https://doi.org/10.1186/s12951-019-0524-9
After publication of this article , an error was found in the description of the holmium isotopes. 165Ho is a stable isotope a fraction of which is activated to 166Ho by neutron activation in a nuclear reactor . In one paragraph of the published article, describing holmium containing QuiremSpheres, 165Ho should be replaced with 166Ho. The correct description is given below:
“QuiremSpheres are poly-l-lactic acid based microspheres, containing 166Ho. The size of the particles varies from 15 to 60 μm and the use of poly-l-lactic acid allows to achieve the particle density of 1.4 g/cm3, which is closer to the density of blood (1.06 g/cm3). The 165Ho is activated to 166Ho with neutron activation in a nuclear reactor. Due to the short half-life period of 166Ho, each patient dose of QuiremSpheres needs to be prepared separately, thus, a specific activity can differ in each dose and depends on the needs of a patient.”
Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. J Nanobiotechnol. 2019;17(1):90. https://doi.org/10.1186/s12951-019-0524-9.
Reinders MTM, Smits MLJ, van Roekel C, Braat AJAT. Holmium-166 microsphere radioembolization of hepatic malignancies. Semin Nucl Med. 2019;49(3):237–43. https://doi.org/10.1053/j.semnuclmed.2019.01.008.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Peltek, O.O., Muslimov, A.R., Zyuzin, M.V. et al. Correction to: Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. J Nanobiotechnol 18, 2 (2020). https://doi.org/10.1186/s12951-019-0558-z